Globe Life Inc
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. It offers whole, term, and other life insurance products; and Medicare supplement and limited-benefit… Read more
Globe Life Inc (GL) - Net Assets
Latest net assets as of September 2025: $5.69 Billion USD
Based on the latest financial reports, Globe Life Inc (GL) has net assets worth $5.69 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($30.53 Billion) and total liabilities ($24.84 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.69 Billion |
| % of Total Assets | 18.64% |
| Annual Growth Rate | 1.02% |
| 5-Year Change | -39.51% |
| 10-Year Change | 30.82% |
| Growth Volatility | 23.05 |
Globe Life Inc - Net Assets Trend (1985–2024)
This chart illustrates how Globe Life Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Globe Life Inc (1985–2024)
The table below shows the annual net assets of Globe Life Inc from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.31 Billion | +18.25% |
| 2023-12-31 | $4.49 Billion | +13.60% |
| 2022-12-31 | $3.95 Billion | -54.30% |
| 2021-12-31 | $8.64 Billion | -1.46% |
| 2020-12-31 | $8.77 Billion | +20.25% |
| 2019-12-31 | $7.29 Billion | +34.70% |
| 2018-12-31 | $5.42 Billion | -13.10% |
| 2017-12-31 | $6.23 Billion | +36.45% |
| 2016-12-31 | $4.57 Billion | +12.61% |
| 2015-12-31 | $4.06 Billion | -13.67% |
| 2014-12-31 | $4.70 Billion | +24.39% |
| 2013-12-31 | $3.78 Billion | -13.42% |
| 2012-12-31 | $4.36 Billion | +3.14% |
| 2011-12-31 | $4.23 Billion | +5.30% |
| 2010-12-31 | $4.02 Billion | +18.16% |
| 2009-12-31 | $3.40 Billion | +52.90% |
| 2008-12-31 | $2.22 Billion | -33.14% |
| 2007-12-31 | $3.32 Billion | -3.89% |
| 2006-12-31 | $3.46 Billion | +0.77% |
| 2005-12-31 | $3.43 Billion | +0.38% |
| 2004-12-31 | $3.42 Billion | +5.55% |
| 2003-12-31 | $3.24 Billion | +8.15% |
| 2002-12-31 | $3.00 Billion | +13.41% |
| 2001-12-31 | $2.64 Billion | +10.27% |
| 2000-12-31 | $2.40 Billion | +9.56% |
| 1999-12-31 | $2.19 Billion | -10.85% |
| 1998-12-31 | $2.45 Billion | +15.37% |
| 1997-12-31 | $2.13 Billion | +16.65% |
| 1996-12-31 | $1.82 Billion | +2.27% |
| 1995-12-31 | $1.78 Billion | +43.41% |
| 1994-12-31 | $1.24 Billion | -12.33% |
| 1993-12-31 | $1.42 Billion | +17.75% |
| 1992-12-31 | $1.20 Billion | +4.68% |
| 1991-12-31 | $1.15 Billion | +14.63% |
| 1990-12-31 | $1.00 Billion | +6.00% |
| 1989-12-31 | $946.30 Million | -75.92% |
| 1988-12-31 | $3.93 Billion | -0.28% |
| 1987-12-31 | $3.94 Billion | -0.78% |
| 1986-12-31 | $3.97 Billion | +11.07% |
| 1985-12-31 | $3.58 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Globe Life Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 859.9% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $8.00 Billion | 150.83% |
| Common Stock | $97.22 Million | 1.83% |
| Other Comprehensive Income | $-2.03 Billion | -38.26% |
| Total Equity | $5.31 Billion | 100.00% |
Globe Life Inc Competitors by Market Cap
The table below lists competitors of Globe Life Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kuehne + Nagel International AG
PINK:KHNGF
|
$10.87 Billion |
|
Eicher Motors Limited
NSE:EICHERMOT
|
$10.89 Billion |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
$10.90 Billion |
|
J Sainsbury PLC OTC
OTCQX:JSAIY
|
$10.91 Billion |
|
Santos Ltd
PINK:STOSF
|
$10.85 Billion |
|
S.F. Holding Co. Ltd
SHE:002352
|
$10.85 Billion |
|
KC40
F:KC40
|
$10.84 Billion |
|
Guangdong Wens Foodstuff Group Co Ltd
SHE:300498
|
$10.83 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Globe Life Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,486,803,000 to 5,305,520,000, a change of 818,717,000 (18.2%).
- Net income of 1,070,762,000 contributed positively to equity growth.
- Dividend payments of 85,485,000 reduced retained earnings.
- Share repurchases of 1,002,109,000 reduced equity.
- New share issuances of 51,786,000 increased equity.
- Other comprehensive income increased equity by 742,699,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.07 Billion | +20.18% |
| Dividends Paid | $85.48 Million | -1.61% |
| Share Repurchases | $1.00 Billion | -18.89% |
| Share Issuances | $51.79 Million | +0.98% |
| Other Comprehensive Income | $742.70 Million | +14.0% |
| Other Changes | $41.06 Million | +0.77% |
| Total Change | $- | 18.25% |
Book Value vs Market Value Analysis
This analysis compares Globe Life Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.20x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 68.07x to 2.20x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $2.02 | $137.62 | x |
| 1986-12-31 | $1.87 | $137.62 | x |
| 1987-12-31 | $2.02 | $137.62 | x |
| 1988-12-31 | $2.06 | $137.62 | x |
| 1989-12-31 | $2.54 | $137.62 | x |
| 1990-12-31 | $2.70 | $137.62 | x |
| 1991-12-31 | $3.13 | $137.62 | x |
| 1992-12-31 | $3.39 | $137.62 | x |
| 1993-12-31 | $4.29 | $137.62 | x |
| 1994-12-31 | $3.86 | $137.62 | x |
| 1995-12-31 | $4.93 | $137.62 | x |
| 1996-12-31 | $5.06 | $137.62 | x |
| 1997-12-31 | $6.18 | $137.62 | x |
| 1998-12-31 | $7.40 | $137.62 | x |
| 1999-12-31 | $6.83 | $137.62 | x |
| 2000-12-31 | $7.63 | $137.62 | x |
| 2001-12-31 | $8.92 | $137.62 | x |
| 2002-12-31 | $10.51 | $137.62 | x |
| 2003-12-31 | $12.49 | $137.62 | x |
| 2004-12-31 | $13.59 | $137.62 | x |
| 2005-12-31 | $14.41 | $137.62 | x |
| 2006-12-31 | $15.21 | $137.62 | x |
| 2007-12-31 | $15.42 | $137.62 | x |
| 2008-12-31 | $11.16 | $137.62 | x |
| 2009-12-31 | $18.19 | $137.62 | x |
| 2010-12-31 | $21.75 | $137.62 | x |
| 2011-12-31 | $25.67 | $137.62 | x |
| 2012-12-31 | $29.70 | $137.62 | x |
| 2013-12-31 | $27.06 | $137.62 | x |
| 2014-12-31 | $35.42 | $137.62 | x |
| 2015-12-31 | $31.99 | $137.62 | x |
| 2016-12-31 | $37.32 | $137.62 | x |
| 2017-12-31 | $52.37 | $137.62 | x |
| 2018-12-31 | $46.99 | $137.62 | x |
| 2019-12-31 | $65.49 | $137.62 | x |
| 2020-12-31 | $81.80 | $137.62 | x |
| 2021-12-31 | $83.77 | $137.62 | x |
| 2022-12-31 | $39.90 | $137.62 | x |
| 2023-12-31 | $46.56 | $137.62 | x |
| 2024-12-31 | $62.60 | $137.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Globe Life Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.18%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.53%
- • Asset Turnover: 0.20x
- • Equity Multiplier: 5.48x
- Recent ROE (20.18%) is above the historical average (16.27%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 17.09% | 12.07% | 0.37x | 3.87x | $68.52 Million |
| 1986 | 22.41% | 13.18% | 0.38x | 4.51x | $113.54 Million |
| 1987 | 21.73% | 12.61% | 0.38x | 4.60x | $108.25 Million |
| 1988 | 22.29% | 10.82% | 0.38x | 5.48x | $99.31 Million |
| 1989 | 23.62% | 12.93% | 0.33x | 5.50x | $121.85 Million |
| 1990 | 24.28% | 12.76% | 0.32x | 5.87x | $134.82 Million |
| 1991 | 22.84% | 12.75% | 0.31x | 5.71x | $138.57 Million |
| 1992 | 23.80% | 12.97% | 0.30x | 6.07x | $153.93 Million |
| 1993 | 21.02% | 13.67% | 0.28x | 5.39x | $156.17 Million |
| 1994 | 21.64% | 13.93% | 0.23x | 6.76x | $144.64 Million |
| 1995 | 9.01% | 6.93% | 0.22x | 5.89x | $-15.66 Million |
| 1996 | 19.11% | 14.12% | 0.23x | 6.02x | $148.44 Million |
| 1997 | 17.47% | 14.80% | 0.21x | 5.67x | $144.47 Million |
| 1998 | 10.82% | 11.33% | 0.19x | 4.98x | $18.49 Million |
| 1999 | 13.74% | 12.30% | 0.18x | 6.09x | $74.62 Million |
| 2000 | 16.44% | 14.37% | 0.19x | 5.89x | $141.76 Million |
| 2001 | 14.28% | 13.17% | 0.22x | 4.98x | $106.80 Million |
| 2002 | 13.58% | 14.03% | 0.22x | 4.33x | $102.14 Million |
| 2003 | 13.27% | 14.67% | 0.22x | 4.15x | $106.09 Million |
| 2004 | 13.70% | 15.25% | 0.22x | 4.17x | $126.58 Million |
| 2005 | 14.43% | 15.85% | 0.21x | 4.30x | $152.11 Million |
| 2006 | 14.99% | 15.16% | 0.23x | 4.33x | $172.71 Million |
| 2007 | 15.87% | 15.13% | 0.23x | 4.58x | $195.07 Million |
| 2008 | 20.35% | 13.59% | 0.25x | 6.09x | $229.97 Million |
| 2009 | 11.91% | 12.57% | 0.20x | 4.71x | $65.06 Million |
| 2010 | 12.42% | 14.81% | 0.21x | 4.02x | $97.24 Million |
| 2011 | 11.76% | 14.72% | 0.20x | 4.06x | $74.27 Million |
| 2012 | 12.14% | 14.75% | 0.19x | 4.30x | $93.15 Million |
| 2013 | 13.99% | 15.12% | 0.19x | 4.82x | $150.84 Million |
| 2014 | 11.56% | 13.69% | 0.20x | 4.30x | $73.19 Million |
| 2015 | 13.00% | 14.00% | 0.19x | 4.90x | $121.54 Million |
| 2016 | 12.04% | 13.97% | 0.18x | 4.69x | $93.09 Million |
| 2017 | 23.33% | 34.99% | 0.18x | 3.77x | $830.86 Million |
| 2018 | 12.95% | 16.29% | 0.19x | 4.26x | $159.48 Million |
| 2019 | 10.43% | 16.80% | 0.17x | 3.56x | $31.36 Million |
| 2020 | 8.34% | 15.45% | 0.16x | 3.31x | $-145.34 Million |
| 2021 | 8.62% | 14.57% | 0.17x | 3.44x | $-119.32 Million |
| 2022 | 18.73% | 14.18% | 0.20x | 6.58x | $344.75 Million |
| 2023 | 21.64% | 17.82% | 0.19x | 6.25x | $522.07 Million |
| 2024 | 20.18% | 18.53% | 0.20x | 5.48x | $540.21 Million |
Industry Comparison
This section compares Globe Life Inc's net assets metrics with peer companies in the Insurance - Life industry.
Industry Context
- Industry: Insurance - Life
- Average net assets among peers: $46,126,949,561
- Average return on equity (ROE) among peers: 18.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Globe Life Inc (GL) | $5.69 Billion | 17.09% | 4.37x | $10.86 Billion |
| AIA Group Ltd (AAIGF) | $212.18 Billion | 2.88% | 0.02x | $75.83 Billion |
| Atlantic American Corporation (AAME) | $27.60 Million | 12.32% | 6.48x | $10.61 Million |
| Abacus Life Inc. (ABL) | $3.58 Million | 40.17% | 0.04x | $276.35 Million |
| Abacus Global Management, Inc. (ABX) | $1.30 Million | 50.90% | 0.12x | $90.05K |
| Aflac Incorporated (AFL) | $6.39 Billion | 12.84% | 6.05x | $55.53 Billion |
| Anadolu Hayat Emeklilik Anonim Sirketi (AUHYF) | $1.88 Billion | 37.14% | 26.33x | $90.55 Million |
| Brighthouse Financial Inc (BHF) | $5.02 Billion | 7.72% | 46.48x | $3.35 Billion |
| Challenger Limited (CFIGF) | $14.49 Billion | 2.06% | 0.28x | $1.66 Billion |
| Citizens Inc (CIA) | $28.30 Million | 19.53% | 3.74x | $208.88 Million |
| China Life Insurance Co Ltd (CILJF) | $221.24 Billion | -2.13% | 0.03x | $16.34 Billion |